Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating The Efficacy And Safety Of CP-526,555 In Smokers Motivated To Stop Smoking

NCT00139750 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00139750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00139750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating The Efficacy And Safety Of CP-526,555 In Smokers Motivated To Stop Smoking
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
February 28, 2006
Enrollment
600
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation